Mapping the translational science policy 'valley of death' - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Clinical and Translational Medicine Année : 2013

Mapping the translational science policy 'valley of death'

Résumé

Translating the knowledge from biomedical science into clinical applications that help patients has been compared to crossing a valley of death because of the many issues that separate the bench from the bedside and threaten to stall progress. But translation is also inhibited by a science policy environment with its own impediments. Mapping these policy impediments give a more complete picture of the valley of death. Stem cell science is one example where success in moving from the bench to the bedside has confronted policy challenges generating difficulties as challenging as those facing scientists and clinicians. We highlight some of the characteristics and challenges of the science policy valley of death common to the U.S. and Europe, illustrate them with a recent example from stem cell science, and describe some promising strategies for traversing the valley.
Fichier principal
Vignette du fichier
2001-1326-2-14.pdf (348.36 Ko) Télécharger le fichier
2001-1326-2-14.xml (55.56 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Format : Autre
Loading...

Dates et versions

inserm-00849416 , version 1 (31-07-2013)

Identifiants

Citer

Eric Meslin, Alessandro Blasimme, Anne Cambon-Thomsen. Mapping the translational science policy 'valley of death'. Clinical and Translational Medicine, 2013, 2 (1), pp.14. ⟨10.1186/2001-1326-2-14⟩. ⟨inserm-00849416⟩
264 Consultations
147 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More